Assess Med Options When Standard Heart Failure Therapy Isn't Enough

We're getting questions about managing patients admitted with heart failure exacerbations despite standard therapy.

First verify adherence to target doses of meds that decrease mortality in heart failure with reduced ejection fraction (HFrEF) ACEI or ARB, an "evidence-based" beta-blocker (carvedilol, etc), plus an aldosterone antagonist. About half of patients may not be adherent.

Weigh the options below if treatment adjustments are needed.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals